Mar 31, 2022

Revolution Medicines Q1 2022 Earnings Report

Total Revenue
$7.58M
Previous year: $10.1M
-25.2%
EPS
-$0.78
Previous year: -$0.53
+47.2%
Gross Profit
$5.29M
Cash and Equivalents
$97.7M
Free Cash Flow
-$57M
Total Assets
$683M

Revolution Medicines

Revolution Medicines